Genetic and environmental risk factors in autistic children

Article Sidebar

PDF HTML
Published: Sep 2, 2024
DOI: https://doi.org/10.29070/dgqkym59
Keywords:
Genetic, Environmental, Risk factors, Autistic, Children

Main Article Content

Authors

Manisha Thakur

Research Scholar, Centre of Psychology and Behavioral Sciences, Shoolini University, Solan, Himachal Pradesh

Dr. Anita Chauhan

Associate Professor, Centre of Psychology and Behavioral Sciences, Shoolini University, Solan, Himachal Pradesh

Abstract

A complex neurodevelopmental disorder known as autism spectrum disorder (ASD) is characterized by difficulties with behavior, socialization, and communication. ASD has a complex etiology, with environmental and genetic variables playing a role in its development. The purpose of this research is to assess our current knowledge of the genetic predispositions and environmental exposures that raise a child's risk of autism spectrum disorder (ASD). To find important risk variables, we examined data from several epidemiological studies, genome-wide association studies (GWAS), and environmental health studies. Our results demonstrate the significant contribution that genetic mutations both inherited and de novo make to the increased risk of ASD. Critical environmental factors that we also discovered were maternal illnesses, prenatal pollution exposure, and dietary deficits. This integrated method emphasizes how important it is to take into account both environmental and genetic elements in order to better understand and maybe lower the risk of ASD.

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 21 No. 1 (2024): Journal of Advances in Science and Technology (JAST)

Section

Articles

References

  1. Ashwood, P., Corbett, B. A., Kantor, A., Schulman, H., Van de Water, J., & Amaral, D. G. (2011). In search of cellular immunophenotypes in the blood of children with autism. PloS one, 6(5), e19299.
  2. Barnard, R. A., Pomaville, M. B., & O'roak, B. J. (2015). Mutations and modeling of the chromatin remodeler CHD8 define an emerging autism etiology. Frontiers in neuroscience, 9, 477.
  3. Ben-David, E., & Shifman, S. (2012). Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLoS genetics, 8(3), e1002556.
  4. Bremer, A., Giacobini, M., Nordenskjöld, M., Brøndum‐Nielsen, K., Mansouri, M., Dahl, N., ... & Schoumans, J. (2010). Screening for copy number alterations in loci associated with autism spectrum disorders by two‐color multiplex ligation‐dependent probe amplification. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153(1), 280-285.
  5. Buxbaum, J. D., Hof, P. R., & Dodge, K. L. (2013). The environment in autism spectrum disorders. In The neuroscience of autism spectrum disorders (pp. 203-214). Elsevier.
  6. Centers for Disease Control and Prevention. (2018). Community report from the autism and developmental disabilities monitoring (ADDM) network. Centers for Disease Control and Prevention.
  7. Chaste, P., & Leboyer, M. (2012). Autism risk factors: genes, environment, and gene-environment interactions. Dialogues in clinical neuroscience, 14(3), 281-292.
  8. Constantino, J. N., & Todd, R. D. (2003). Autistic traits in the general population: a twin study. Archives of general psychiatry, 60(5), 524-530.
  9. Constantino, J. N., Zhang, Y. I., Frazier, T., Abbacchi, A. M., & Law, P. (2010). Sibling recurrence and the genetic epidemiology of autism. American Journal of Psychiatry, 167(11), 1349-1356.
  10. Durkin, M. S., Maenner, M. J., Newschaffer, C. J., Lee, L. C., Cunniff, C. M., Daniels, J. L., ... & Schieve, L. A. (2008). Advanced parental age and the risk of autism spectrum disorder. American journal of epidemiology, 168(11), 1268-1276.
  11. Gardener, H., Spiegelman, D., & Buka, S. L. (2011). Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics, 128(2), 344-355.
  12. Goines, P. E., & Ashwood, P. (2013). Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicology and teratology, 36, 67-81.
  13. Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., ... & Risch, N. (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Archives of general psychiatry, 68(11), 1095-1102.
  14. Hvidtjørn, D., Schieve, L., Schendel, D., Jacobsson, B., Sværke, C., & Thorsen, P. (2009). Cerebral palsy, autism spectrum disorders, and developmental delay in children born after assisted conception: a systematic review and meta-analysis. Archives of pediatrics & adolescent medicine, 163(1), 72-83.
  15. Kim, Y. S., Leventhal, B. L., Koh, Y. J., Fombonne, E., Laska, E., Lim, E. C., ... & Grinker, R. R. (2011). Prevalence of autism spectrum disorders in a total population sample. American Journal of Psychiatry, 168(9), 904-912.
  16. Lichtenstein, P., Carlström, E., Råstam, M., Gillberg, C., & Anckarsäter, H. (2010). The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. American Journal of Psychiatry, 167(11), 1357-1363.
  17. Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., ... & Scherer, S. W. (2008). Structural variation of chromosomes in autism spectrum disorder. The American Journal of Human Genetics, 82(2), 477-488.
  18. Modabbernia, A., Velthorst, E., & Reichenberg, A. (2017). Environmental risk factors for autism: An evidence-based review of systematic reviews and meta-analyses. Molecular Autism, 8, 13.
  19. Morgan, J. T., Chana, G., Pardo, C. A., Achim, C., Semendeferi, K., Buckwalter, J., ... & Everall, I. P. (2010). Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biological psychiatry, 68(4), 368-376.
  20. Neale, B. M., Kou, Y., Liu, L., Ma’Ayan, A., Samocha, K. E., Sabo, A., ... & Daly, M. J. (2012). Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature, 485(7397), 242-245.
  21. Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., ... & Windham, G. C. (2007). The epidemiology of autism spectrum disorders. Annual review of public health, 28(1), 235-258.
  22. Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z. (2015). Prenatal factors associated with autism spectrum disorder (ASD). Reproductive toxicology, 56, 155-169.
  23. O'Roak, B. J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J. J., Girirajan, S., ... & Eichler, E. E. (2011). Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature genetics, 43(6), 585-589.
  24. O'Roak, B. J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J. J., Girirajan, S., ... & Eichler, E. E. (2011). Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature genetics, 43(6), 585-589.
  25. Parker, S. K., Schwartz, B., Todd, J., & Pickering, L. K. (2004). Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics, 114(3), 793-804.
  26. Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., ... & Yaspan, B. L. (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466(7304), 368-372.
  27. Pugsley, K., Scherer, S. W., Bellgrove, M. A., & Hawi, Z. (2022). Environmental exposures associated with elevated risk for autism spectrum disorder may augment the burden of deleterious de novo mutations among probands. Molecular psychiatry, 27(1), 710-730.
  28. Quach, H., Ritchie, D., Stewart, A. K., Neeson, P., Harrison, S., Smyth, M. J., & Prince, H. M. (2010). Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia, 24(1), 22-32.
  29. Rasalam, A. D., Hailey, H., Williams, J. H. G., Moore, S. J., Turnpenny, P. D., Lloyd, D. J., & Dean, J. C. (2005). Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental medicine and child neurology, 47(8), 551-555.
  30. Ratajczak, H. V. (2011). Theoretical aspects of autism: Causes—A review. Journal of immunotoxicology, 8(1), 68-79.
  31. Ronald, A., Happe, F., Price, T. S., Baron-Cohen, S., & Plomin, R. (2006). Phenotypic and genetic overlap between autistic traits at the extremes of the general population. Journal of the American Academy of Child & Adolescent Psychiatry, 45(10), 1206-1214.
  32. Smith, S. E., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007). Maternal immune activation alters fetal brain development through interleukin-6. Journal of Neuroscience, 27(40), 10695-10702.
  33. Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 57(1), 67-81.
  34. Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., ... & Geschwind, D. H. (2011). Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature, 474(7351), 380-384.
  35. Volaki, K. (2012). Molecular study of patients with autistic behavior (Doctoral dissertation, National and Kapodistrian University of Athens (EKPA). School of Health Sciences. Department of Medicine. Department of Maternal and Child Health. Laboratory of Medical Genetics).
  36. Willsey, A. J., Sanders, S. J., Li, M., Dong, S., Tebbenkamp, A. T., Muhle, R. A., ... & Sestan, N. (2013). Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell, 155(5), 997-1007.
  37. Zafeiriou, D. I., Ververi, A., Dafoulis, V., Kalyva, E., & Vargiami, E. (2013). Autism spectrum disorders: the quest for genetic syndromes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162(4), 327-366.